Background: Vitamin D (VitD) has important health implications for calcium and bone metabolism in preterm neonates, which may be affected by maternal VitD status. The aims of this study were to determine the prevalence of VitD deficiency/insufficency in mothers of preterm neonates; and determine if the current level of VitD supplementation used for preterm neonates is appropriate.
COMPARISON OF MATERNAL AND PERINATAL OUTCOMES IN WOMEN WITH SUPER OBESITY BASED ON MODE OF DELIVERY: PLANNED VAGINAL BIRTH VS. PLANNED CESAREAN SECTION
Background: Currently, little evidence exists to guide mode of delivery in pregnant women with super obesity. There is a trend towards elective caesarean delivery in this population with little evidence of improved maternal or neonatal outcomes. Our study compares maternal and neonatal outcomes based on planned mode of delivery and aims to identify predictors for a successful vaginal delivery.
Methods: This retrospective observational study explored maternal and neonatal outcomes of women with a BMI ≥ 50 who birthed a singleton pregnancy ≥36 weeks gestation over a 10-year period. Outcomes between women having a planned vaginal or planned caesarean birth were compared, with logistic regression used to determine factors predictive of a vaginal birth.
Results: 275 women with super obesity were identified. 199 (72%) planned a vaginal birth, which was successful for 70%. Planned vaginal birth was associated with lower rates of postpartum hemorrhage (38% vs. 61%; p=0.001) and postpartum complications requiring readmission (5% vs. 16%; p=0.003) ( Table 1) . Neonatal resuscitation requirements and Apgar scores at 5 minutes were similar between groups (Table 2) . Multiparity was the strongest predictor of successful vaginal birth while medical intervention in labor was associated with a reduced rate of success. No difference in the rate of adverse outcomes was seen between women having an emergency or elective caesarean.
Conclusions: Contrary to current trends in practice a trial of labour for women with super obesity, when facilities and skills permit, appears the safest option for mother and baby. Background: Children born extremely preterm (EP; ≤28 weeks gestation or <1000 g) have elevated rates of working memory difficulties that contribute to their academic underachievement. While working memory training has shown promise in this population, there is little evidence to support long-term training benefits, particularly for academic functioning and using rigorous study design methodologies. This randomised controlled trial aimed to assess the effectiveness of a computerised working memory training program (Cogmed) in improving 1) long-term academic functioning two years post-training and 2) short-and long-term working memory and attention skills, compared with a placebo program in EP 7-year-olds.
Methods: Ninety-one EP 7-year-old children were randomised to either Cogmed or the placebo program (1:1 ratio), and underwent intensive, computerised training in the home for 5-7 weeks. Assessment of academic functioning, working memory, attention and behaviour were conducted prior to training (baseline) and at 2 weeks, 1 year and 2 years post-training.
Results: Using mixed-effects regression models, there was little evidence for a Cogmed benefit in academic outcomes 2 years post-training, or at earlier time-points compared with the placebo group. Similarly, there was little evidence of a treatment effect for working memory, attention or behavioural outcomes at all follow-up time points.
Conclusions: There is little benefit of working memory training for working memory or academic outcomes in EP children at early school-age. Background: Preterm birth is the largest contributor to neonatal mortality and morbidity worldwide, and is strongly linked with in-utero inflammation/chorioamnionitis. Infants born preterm, and with chorioamnionitis, are at high risk of white matter brain injury and long-term neurological impairment, like cerebral palsy. An immunomodulatory therapy would be an optimal treatment strategy. This study aimed to assess the efficacy of mesenchymal stem cells (MSCs) in a large animal model of inflammation-induced brain injury.
MESENCHYMAL STEM CELLS MODULATE BRAIN
Methods: Chronically instrumented fetal sheep at 0.65 gestation were administered IV LPS (150 ng, 055:B5) or saline for controls, over 3 consecutive days. Stem cell treated animals received IV 10 million human umbilical cord MSCs, 6 hours after the final LPS dose. Seven days later, CSF was collected, and brains processed for histological analysis of subcortical and periventricular white matter (SCWM & PVWM).
Results: Neuroinflammation and cell death were evident within the brains of LPS-treated animals with significant increases in lectin aggregates and caspase-3 in SCWM and PVWM, together with IL1β elevation in CSF. LPS reduced oligodendrocyte counts (Olig-2 and MBP) in the PVWM and SCWM. MSC treatment prevented the increase in IL1β, and significantly increased levels of IL10 in the CSF. MSC treatment attenuated cell death and lectin aggregation, but did not recover the loss of total and mature oligodendrocytes.
Conclusions: MSCs protected the preterm brain against inflammation and cell death but did not rescue the loss of myelinating oligodendrocytes. Given the white matter is not protected by MSCs, future studies may investigate combining MSCs with a cell therapy that can initiate white matter repair.
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